Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000246 · ClinicalTrials.gov registry record · Phase 2
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00000246 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 10 participants.
The verdict
NCT00000246, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
Interventions
- DRUG Flumazenil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 1993-01 |
| Est. Completion | 1994-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000246
The ClinicalTrials.gov registry entry for NCT00000246 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flumazenil is the first listed.
NCT00000246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000246 about?
NCT00000246 is a clinical study titled "Rapid Benzodiazepine Detoxification Using Flumazenil - 1". The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
What is the current status of trial NCT00000246?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 1993-01. Estimated completion is 1994-12.
What interventions are being tested in trial NCT00000246?
The interventions under investigation include: Flumazenil (DRUG).
Who is sponsoring clinical trial NCT00000246?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.